Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
20
self-reported 11–50 band
Founded
2017
9 years
Legal entities
1
ABR
Office countries
5
5 addresses
Funding rounds
None on record
Company type
Partnership
self-reported
Legal entity
1 brand → 1 confirmed entity
BIOINNOVA PTY LTD
ABN57626541955
Legal entities
Show as table · BioInnova: 1 registry entity
| BIOINNOVA PTY LTD | ABN 57626541955 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
BioInnova is a dynamic pharmaceutical company that is leading the way in ground breaking discoveries and advancements in the field of healthcare. With a strong focus on innovation, research, and patient-centric solutions, we are dedicated to improving the lives of individuals across the globe.
At BioInnova, our passion lies in harnessing the power of science and technology to develop innovative pharmaceutical products and therapies. Our team of brilliant scientists, researchers, and medical professionals work tirelessly to uncover new insights, explore novel treatment modalities, and pioneer advancements in areas such as biotechnology, genomics, and precision medicine.
With a commitment to addressing unmet medical needs, we prioritize therapeutic areas where patients lack effective treatment options. Our portfolio encompasses a diverse range of therapeutic areas, including rare diseases, oncology, neurology, and autoimmune disorders. We believe that every patient deserves access to life-saving medications and strive to make a meaningful impact in their lives.
Collaboration is at the heart of our approach. We actively seek partnerships and alliances with renowned academic institutions, biotech startups, and healthcare organizations to foster an ecosystem of innovation.
At BioInnova, we adhere to the highest standards of quality, safety, and regulatory compliance. Our dedicated teams ensure that our products undergo rigorous testing, robust clinical trials, and stringent manufacturing processes. We are committed to meeting and exceeding regulatory requirements to ensure the safety and efficacy of our pharmaceuticals.
Furthermore, we understand the importance of patient empowerment and engagement.
Join us on our mission to revolutionize healthcare and create a healthier world for all.
Locations
5
Countries with an office address5 addresses on record
Country footprint
Show as table · Offices in 5 countries
| Countries | 5 |
|---|---|
| Primary country | AU |
All codes: AU FJ IN NZ US
Addresses
- AUSydney, NSWPrimary
- INMumbai, Maharashtra
- USAustin, Texas
- NZAuckland
- FJNadi
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
Which legal entity operates under BioInnova?
One New South Wales entity on the ABR: BIOINNOVA PTY LTD (ABN 57 626 541 955), high confidence.
How many people work at BioInnova?
20 counted staff profiles at January 2026, inside the self-reported 11–50 band.
Where does BioInnova have offices?
Five addresses on record across 5 countries. Primary: Sydney, NSW.
Has BioInnova raised funding?
None linked to this brand.
Which companies are listed alongside BioInnova?
5 profiles list BioInnova as a peer — 72nd percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Syntara and Arna Pharma list it back.